Table 2.
Techniques | Advantages | Disadvantages | References | |
---|---|---|---|---|
Genomics | Southern blot, microarray, northern blot, sequencing, PFGE, FIGE | (a) Genetic basis of observed phenotype (b) Large genome coverage (22–97.5%) (c) Easy to perform and interpret (d) Reproducible |
(a) Not much differences amongst species at genome level (b) Not much informative (c) Gene functions for most genes still unknown. |
[7, 8, 14, 15, 22, 37, 41, 42, 44, 47, 51, 62] |
| ||||
Proteomics | 2DE, MALDI-TOF, LC-MS/MS, LC-ESI-MS/MS, western blot, immunoblot | (a) Functional output of the cell (b) Posttranslational changes visualised (c) Mostly automated (d) Good indicator of protein abundance and expression |
(a) Number of proteins lack annotated functions (b) Less abundant proteins hard to detect (c) Results from in vivo amastigotes difficult to interpret (d) Not reproducible in some cases |
[6, 20, 23, 29, 30, 40, 49, 51, 51] |
| ||||
Metabolomics | CE-ESI-TOF-MS, HPLC, MALDI-TOF, flow cytometry, GC-MS | (a) Closest correlation to phenotype (b) Rapid visualisation and prediction of biological impact (c) High mass accuracy (d) Highly specific |
(a) Unable to quantify most of the metabolites. (b) Analyte derivatives make data complex (c) Data hard to analyse (d) Complicated bioinformatics tools needed (e) Costly instrumentation |
[4, 5, 22, 24, 32, 35, 41, 43, 48, 51] |
PFGE: pulsed field gel electrophoresis; FIGE: field inversion gel electrophoresis; 2DE: two-dimensional gel electrophoresis; MALDI-TOF MS: matrix assisted laser desorption/ionisation time of flight mass spectrometry; LC-MS/MS: liquid chromatography mass spectra/mass spectrometry; LC-ESI-MS/MS: liquid chromatography electrospray ionisation tandem mass spectrometry; CE-ESI-TOF-MS: capillary electrophoresis mass spectrometry coupled with electrospray ionisation mass spectrometry; HPLC: high performance liquid chromatography; GC-MS: gas chromatography mass spectrometry.